UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.286

Sortiert nach

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies

Annals of oncology, 2014-11, Vol.25 (11), p.2277-2284

2014

Volltextzugriff (PDF)

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

Annals of oncology, 2010-08, Vol.21 (8), p.1712-1717

2010

Volltextzugriff (PDF)

Relationship between cancer patients' predictions of prognosis and their treatment preferences

JAMA : the journal of the American Medical Association, 1998-06, Vol.279 (21), p.1709

1998

Volltextzugriff (PDF)

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

British journal of cancer, 2001, Vol.84 (2), p.157-163

2001

Volltextzugriff (PDF)

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii732-viii732

2018

Volltextzugriff (PDF)

Advantages of Concurrent Biochemotherapy Modified by Decrescendo Interleukin-2, Granulocyte Colony-Stimulating Factor, and Tamoxifen for Patients With Metastatic Melanoma

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2752-2761

1999

Volltextzugriff (PDF)

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma

Journal of clinical oncology, 2002-01, Vol.20 (1), p.125-133

Agarwala, S. S.

2002

Volltextzugriff (PDF)

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma

Recent results in cancer research, 2001, Vol.158, p.78

2001

Volltextzugriff (PDF)

Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (12), p.4085-4088

2004

Volltextzugriff (PDF)

Circulating DNA microsatellites: Molecular determinants of response to biochemotherapy in patients with metastatic melanoma

JNCI : Journal of the National Cancer Institute, 2004-01, Vol.96 (2), p.152-156

2004

Volltextzugriff (PDF)

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

Neurosurgery, 1999-01, Vol.44 (1), p.59-64

1999

Volltextzugriff (PDF)

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial

Melanoma research, 2011-12, Vol.21 (6), p.530-534

2011

Volltextzugriff (PDF)

Molecular Detection of Metastatic Melanoma Cells in Cerebrospinal Fluid in Melanoma Patients

Journal of investigative dermatology, 2001-08, Vol.117 (2), p.375-378

2001

Volltextzugriff (PDF)

LBA40Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

High‐dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin‐2 in patients with metastatic melanoma

Cancer, 2001-08, Vol.92 (3), p.609-619

2001

Volltextzugriff (PDF)

Phase III, randomized, double-blind study of elesclomol and paclitaxel versus paclitaxel alone in stage IV metastatic melanoma (MM)

Journal of clinical oncology, 2009-06, Vol.27 (18S), p.LBA9012-LBA9012

2009

Volltextzugriff (PDF)

Phase III, randomized, double-blind study of elesclomol and paclitaxel versus paclitaxel alone in stage IV metastatic melanoma (MM)

Journal of clinical oncology, 2009-06, Vol.27 (18_suppl), p.LBA9012-LBA9012

2009

Volltextzugriff (PDF)

Phase III, randomized, double-blind study of elesclomol and paclitaxel versus paclitaxel alone in stage IV metastatic melanoma (MM)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.LBA9012-LBA9012

2009

Volltextzugriff (PDF)

Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9351-9358

2005

Volltextzugriff (PDF)

Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial

Journal of clinical oncology, 2005-11, Vol.23 (31), p.8057-8064

2005

Volltextzugriff (PDF)

Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine

Journal of clinical oncology, 2002-12, Vol.20 (23), p.4549-4554

2002

Volltextzugriff (PDF)

Abstract OT1-01-04: A phase 2, open-label study of imprime PGG (Imprime), a novel beta glucan, with pembrolizumab (Pembro) in chemotherapy-resistant metastatic triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT1-01-04-OT1-01-04

2018

Volltextzugriff (PDF)

Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients

Annals of the New York Academy of Sciences, 2004-06, Vol.1022 (1), p.17-24

2004

Volltextzugriff (PDF)

Multimarker Quantitative Real-Time PCR Detection of Circulating Melanoma Cells in Peripheral Blood: Relation to Disease Stage in Melanoma Patients

Clinical chemistry (Baltimore, Md.), 2005-06, Vol.51 (6), p.981-988

2005

Volltextzugriff (PDF)

Long-term survival of patients with advanced melanoma who received ipilimumab administered at 10 mg/kg every 3 weeks for 4 doses (induction dosing)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3018-3018

2008

Volltextzugriff (PDF)

1 – 25 von 1.286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.178)
Mit Volltextzugriff
(712)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study

Relationship between cancer patients' predictions of prognosis and their treatment preferences

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

Advantages of Concurrent Biochemotherapy Modified by Decrescendo Interleukin-2, Granulocyte Colony-Stimulating Factor, and Tamoxifen for Patients With Metastatic Melanoma

Results From a Randomized Phase III Study Comparing Combined Treatment With Histamine Dihydrochloride Plus Interleukin-2 Versus Interleukin-2 Alone in Patients With Metastatic Melanoma

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma

Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome

Circulating DNA microsatellites: Molecular determinants of response to biochemotherapy in patients with metastatic melanoma

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial

Molecular Detection of Metastatic Melanoma Cells in Cerebrospinal Fluid in Melanoma Patients

LBA40Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients

High‐dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin‐2 in patients with metastatic melanoma

Phase III, randomized, double-blind study of elesclomol and paclitaxel versus paclitaxel alone in stage IV metastatic melanoma (MM)

Phase III, randomized, double-blind study of elesclomol and paclitaxel versus paclitaxel alone in stage IV metastatic melanoma (MM)

Phase III, randomized, double-blind study of elesclomol and paclitaxel versus paclitaxel alone in stage IV metastatic melanoma (MM)

Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving Biochemotherapy

Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial

Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine

Abstract OT1-01-04: A phase 2, open-label study of imprime PGG (Imprime), a novel beta glucan, with pembrolizumab (Pembro) in chemotherapy-resistant metastatic triple negative breast cancer (TNBC)

Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients

Multimarker Quantitative Real-Time PCR Detection of Circulating Melanoma Cells in Peripheral Blood: Relation to Disease Stage in Melanoma Patients

Long-term survival of patients with advanced melanoma who received ipilimumab administered at 10 mg/kg every 3 weeks for 4 doses (induction dosing)

Suchergebnisse filtern